See HT - Search Results

1

See HT, Hsu A. See HT, et al. Singapore Med J. 1999 Jul;40(7):477-9. Singapore Med J. 1999. PMID: 10560275

2

Attitudes towards cancer survivors: a small survey.

Chen HM, Tan WH, Tan WC, Yu CK, Lim TH, Tay MH, See HT. Chen HM, et al. Among authors: see ht. Singapore Med J. 2006 Feb;47(2):143-6. Singapore Med J. 2006. PMID: 16435057 Free article.

3

Efficacy and tolerability of irinotecan in patients with advanced colorectal cancer in Singapore.

See HT, Koo WH, Ang P, Au E, Ang PT. See HT, et al. Ann Acad Med Singap. 2002 Sep;31(5):651-5. Ann Acad Med Singap. 2002. PMID: 12395655 Clinical Trial.

4

Phase I/II study of gemcitabine with pegylated liposomal doxorubicin as first-line therapy in Asian women with metastatic breast cancer.

Wong ZW, Ang PC, Chowbay B, Wong NS, See HT, Khoo KS. Wong ZW, et al. Among authors: see ht. Breast. 2008 Oct;17(5):517-22. doi: 10.1016/j.breast.2008.03.009. Epub 2008 May 23. Breast. 2008. PMID: 18502128 Free article. Clinical Trial.

5

Acceptance of prophylactic surgery and chemoprevention of cancer in Singapore - a survey.

See HT, Cheung YB, Yong F, Khoo KS, Ang P. See HT, et al. Ann Acad Med Singap. 2005 Apr;34(3):238-42. Ann Acad Med Singap. 2005. PMID: 15902344 Free article.

6

Retrospective review: re-treatment of patients with ovarian cancer with carboplatin after platinum resistance.

See HT, Freedman RS, Kudelka AP, Burke TW, Gershenson DM, Tangjitgamol S, Kavanagh JJ. See HT, et al. Int J Gynecol Cancer. 2005 Mar-Apr;15(2):209-16. doi: 10.1111/j.1525-1438.2005.15205.x. Int J Gynecol Cancer. 2005. PMID: 15823101 Free article.

7

Novel agents in epithelial ovarian cancer.

See HT, Kavanagh JJ. See HT, et al. Cancer Invest. 2004;22 Suppl 2:29-44. doi: 10.1081/cnv-200030119. Cancer Invest. 2004. PMID: 15573743 Review.

8

Secondary leukemia after treatment with paclitaxel and carboplatin in a patient with recurrent ovarian cancer.

See HT, Thomas DA, Bueso-Ramos C, Kavanagh J. See HT, et al. Int J Gynecol Cancer. 2006 Jan-Feb;16 Suppl 1:236-40. doi: 10.1111/j.1525-1438.2006.00491.x. Int J Gynecol Cancer. 2006. PMID: 16515597

9

Combined adjuvant cisplatin and ifosfamide chemotherapy and radiotherapy for malignant mixed müllerian tumors of the uterus.

Wong L, See HT, Khoo-Tan HS, Low JS, Ng WT, Low JJ. Wong L, et al. Among authors: see ht. Int J Gynecol Cancer. 2006 May-Jun;16(3):1364-9. doi: 10.1111/j.1525-1438.2006.00560.x. Int J Gynecol Cancer. 2006. PMID: 16803531

10

Third-line chemotherapy in platinum- and paclitaxel-resistant ovarian, fallopian tube, and primary peritoneal carcinoma patients.

Tangjitgamol S, See HT, Manusirivithaya S, Levenback CF, Gershenson DM, Kavanagh JJ. Tangjitgamol S, et al. Among authors: see ht. Int J Gynecol Cancer. 2004 Sep-Oct;14(5):804-14. doi: 10.1111/j.1048-891X.2004.014512.x. Int J Gynecol Cancer. 2004. PMID: 15361188

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page